Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
AMPH

Market Cap: $1.05B

AI

Amphastar Pharmaceuticals, Inc.

AMPH

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin47.68%

EBITDA Margin23.94%

EBIT Margin17.55%

Pre-tax Margin13.98%

Net Profit Margin10.76%

Earnings Yield7.57%

Valuation Multiples

Price / Book1.35

Price / Sales1.44

Price / Earnings13.67

PEG-0.36

Forward PEG1.93

EV / Sales2.07

EV / EBITDA8.66

EV / Operating Cash Flow8.20

EV / Free Cash Flow9.90

Price / Free Cash Flow6.86

Price / Operating Cash Flow5.62

Cash Flow & Capital

Free Cash Flow / Share$3.5

Operating Cash Flow / Share$4.23

Free Cash Flow Yield14.58%

Capex / Revenue4.34%

Capex / Operating Cash Flow17.18%

Capex / Depreciation0.50

Stock Compensation / Revenue3.95%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.40

Quick Ratio1.71

Cash Ratio0.85

Debt / Assets0.39

Debt / Capital0.47

Debt / Equity0.90

Long-Term Debt / Capital0.44

Debt / Market Cap58.37%

Net Debt / EBITDA2.66

Solvency Ratio0.13

Financial Leverage2.27

Efficiency & Working Capital

Asset Turnover0.42

Fixed Asset Turnover1.88

Inventory Turnover2.12

Receivables Turnover5.04

Payables Turnover13.20

Days Sales Outstanding72.43

Days Inventory Outstanding171.94

Days Payables Outstanding27.65

Operating Cycle244.37

Cash Conversion Cycle216.72

Working Capital Turnover1.74

Returns & Quality

Return on Equity10.11%

Return on Assets4.50%

Return on Invested Capital5.90%

ROCE7.72%

Return on Tangible Assets6.67%

Operating Return on Assets6.74%

Income Quality2.35

Tax Burden0.77

Interest Burden0.80

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.51B

Invested Capital$1.32B

Working Capital$367.75M

Tangible Asset Value$202.19M

Net Current Asset Value$-344.66M

Graham Number$26.7

Graham Net-Net-$11.16

Book Value / Share$17.6

Tangible Book Value / Share$4.63

Cash / Share$6.65

Financial Health Scores

Piotroski Score6

Altman Z-Score2.12

Revenue$730.02M

EBIT$128.15M

Market Cap$1.05B

Working Capital$367.75M

Retained Earnings$703.65M

Total Assets$1.74B

Total Liabilities$975.61M